IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers

Journal of Proteome Research

Volumn 12, Issue 9, 2013, Pages 3969-3979

  Frantzi, Maria ^a,c   Zoidakis, Jerome ^a   Papadopoulos, Theofilos ^a   Zürbig, Petra ^c   Katafigiotis, Ioannis ^d   Stravodimos, Konstantinos ^d   Lazaris, Andreas ^e   Giannopoulou, Ioanna ^e   Ploumidis, Achilles ^f   Mischak, Harald ^b,c   Mullen, William ^b   Vlahou, Antonia ^a  

^a Academy of Athens Biomedical Research Foundation   (Greece)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f ATHENS MEDICAL CENTER   (Greece)

Author keywords

bladder cancer; H2B; NIF 1; peptidomics; urine

Indexed keywords

BIOLOGICAL MARKER; HISTONE H2B; PEPTIDE; PROTEIN NIF 1; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTIONATION; HUMAN; HUMAN TISSUE; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; TISSUE SECTION; TUMOR GROWTH; URINALYSIS; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELL FRACTIONATION; CHROMATOGRAPHY, AFFINITY; FEMALE; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM GRADING; NUCLEAR PROTEINS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84883763953     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400255h     Document Type: Article

References (55)

1. Ploeg, M.; Aben, K. K.; Kiemeney, L. A. The present and future burden of urinary bladder cancer in the world World J. Urol. 2009, 27 (3) 289-93
2. Cheng, L.; Montironi, R.; Davidson, D. D.; Lopez-Beltran, A. Staging and reporting of urothelial carcinoma of the urinary bladder Mod. Pathol. 2009, 22 (Suppl 2) S70-95
3. Sobin, L. H.; Gospodarowicz, M.; Wittekind, C., Eds.; TNM Classification of Malignant Tumours, 7th ed; UICC International Union Against Cancer, Wiley-Blackwell: New York, NY, 2009, p 262-5.
4. Shariat, S. F.; Chade, D. C.; Karakiewicz, P. I.; Ashfaq, R.; Isbarn, H.; Fradet, Y.; Bastian, P. J.; Nielsen, M. E.; Capitanio, U.; Jeldres, C.; Montorsi, F.; Lerner, S. P.; Sagalowsky, A. I.; Cote, R. J.; Lotan, Y. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer J. Urol. 2010, 183 (1) 68-75
5. Li, H. X.; Wang, M. R.; Zhao, H.; Cao, J.; Li, C. L.; Pan, Q. J. Comparison of fluorescence in situ hybridization, NMP22 BladderChek, and urinary liquid-based cytology in the detection of bladder urothelial carcinoma. Diagn. Cytopathol. 2013, 10.1002/dc.22969.
6. Frantzi, M.; Makridakis, M.; Vlahou, A. Biomarkers for bladder cancer aggressiveness Curr. Opin. Urol. 2012, 22 (5) 390-6
7. Vlahou, A. Back to the future in bladder cancer research Expert Rev. Proteomics 2011, 8 (3) 295-7
8. Lotan, Y.; Shariat, S. F.; Schmitz-Drager, B. J.; Sanchez-Carbayo, M.; Jankevicius, F.; Racioppi, M.; Minner, S. J.; Stohr, B.; Bassi, P. F.; Grossman, H. B. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer Urol. Oncol. 2010, 28 (4) 441-8
9. Decramer, S.; Gonzalez de Peredo, A.; Breuil, B.; Mischak, H.; Monsarrat, B.; Bascands, J. L.; Schanstra, J. P. Urine in clinical proteomics Mol. Cell. Proteomics 2008, 7 (10) 1850-62
10. Zoidakis, J.; Makridakis, M.; Zerefos, P. G.; Bitsika, V.; Esteban, S.; Frantzi, M.; Stravodimos, K.; Anagnou, N. P.; Roubelakis, M. G.; Sanchez-Carbayo, M.; Vlahou, A. Profilin 1 is a potential biomarker for bladder cancer aggressiveness Mol. Cell. Proteomics 2012, 11 (4) M111 009449
11. Mischak, H.; Kolch, W.; Aivaliotis, M.; Bouyssie, D.; Court, M.; Dihazi, H.; Dihazi, G. H.; Franke, J.; Garin, J.; Gonzalez de Peredo, A.; Iphofer, A.; Jansch, L.; Lacroix, C.; Makridakis, M.; Masselon, C.; Metzger, J.; Monsarrat, B.; Mrug, M.; Norling, M.; Novak, J.; Pich, A.; Pitt, A.; Bongcam-Rudloff, E.; Siwy, J.; Suzuki, H.; Thongboonkerd, V.; Wang, L. S.; Zoidakis, J.; Zurbig, P.; Schanstra, J. P.; Vlahou, A. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis Proteomics Clin. Appl. 2010, 4 (4) 464-78
12. Ruifrok, A. C.; Johnston, D. A. Quantification of histochemical staining by color deconvolution Anal. Quant. Cytol. Histol. 2001, 23 (4) 291-9
13. Siwy, J.; Mullen, W.; Golovko, I.; Franke, J.; Zurbig, P. Human urinary peptide database for multiple disease biomarker discovery Proteomics Clin. Appl. 2011, 5 (5-6) 367-74
14. Block, H.; Maertens, B.; Spriestersbach, A.; Brinker, N.; Kubicek, J.; Fabis, R.; Labahn, J.; Schafer, F., Reprint of: Immobilized-Metal Affinity Chromatography (IMAC): A Review. Protein Expr. Purif. 2011.
15. Beltran, L.; Cutillas, P. R. Advances in phosphopeptide enrichment techniques for phosphoproteomics Amino Acids 2012, 43 (3) 1009-24
16. Cheung, R. C.; Wong, J. H.; Ng, T. B. Immobilized metal ion affinity chromatography: A review on its applications Appl. Microbiol. Biotechnol. 2012, 96 (6) 1411-20
17. Reid, C. N.; Stevenson, M.; Abogunrin, F.; Ruddock, M. W.; Emmert-Streib, F.; Lamont, J. V.; Williamson, K. E. Standardization of diagnostic biomarker concentrations in urine: The hematuria caveat PLoS One 2012, 7 (12) e53354
18. Garapaty, S.; Xu, C. F.; Trojer, P.; Mahajan, M. A.; Neubert, T. A.; Samuels, H. H. Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation J. Biol. Chem. 2009, 284 (12) 7542-52
19. Roos, P. H.; Jakubowski, N. Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids Bioanalysis 2010, 2 (2) 295-309
20. Gonzalez-Ortega, O.; Porath, J.; Guzman, R. Adsorption of peptides and small proteins with control access polymer permeation to affinity binding sites. Part II: Polymer permeation-ion exchange separation adsorbents with polyethylene glycol and strong anion exchange groups J. Chromatogr. A 2012, 1227, 126-37
21. Ye, J.; Zhang, X.; Young, C.; Zhao, X.; Hao, Q.; Cheng, L.; Jensen, O. N. Optimized IMAC-IMAC protocol for phosphopeptide recovery from complex biological samples J. Proteome Res. 2010, 9 (7) 3561-73
22. Feng, S.; Ye, M.; Zhou, H.; Jiang, X.; Zou, H.; Gong, B. Immobilized zirconium ion affinity chromatography for specific enrichment of phosphopeptides in phosphoproteome analysis Mol. Cell. Proteomics 2007, 6 (9) 1656-65
23. Jeong, S.; Park, Y.; Cho, Y.; Kim, Y. R.; Kim, H. S. Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer Clin. Chim. Acta 2012, 414, 93-100
24. Memon, A. A.; Chang, J. W.; Oh, B. R.; Yoo, Y. J. Identification of differentially expressed proteins during human urinary bladder cancer progression Cancer Detect. Prev. 2005, 29 (3) 249-55
25. Chen, Y. T.; Chen, C. L.; Chen, H. W.; Chung, T.; Wu, C. C.; Chen, C. D.; Hsu, C. W.; Chen, M. C.; Tsui, K. H.; Chang, P. L.; Chang, Y. S.; Yu, J. S. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology J. Proteome Res. 2010, 9 (11) 5803-15
26. Gecks, T.; Junker, K.; Franz, M.; Richter, P.; Walther, M.; Voigt, A.; Neri, D.; Kosmehl, H.; Wunderlich, H.; Kiehntopf, M.; Berndt, A. B domain containing Tenascin-C: A new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder? Clin. Chim. Acta 2011, 412 (21-22) 1931-6
27. Chen, Y. T.; Chen, H. W.; Domanski, D.; Smith, D. S.; Liang, K. H.; Wu, C. C.; Chen, C. L.; Chung, T.; Chen, M. C.; Chang, Y. S.; Parker, C. E.; Borchers, C. H.; Yu, J. S. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers J. Proteomics 2012, 75 (12) 3529-45
28. Eissa, S.; Zohny, S. F.; Shehata, H. H.; Hegazy, M. G.; Salem, A. M.; Esmat, M. Urinary retinoic acid receptor-beta2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer Clin. Biochem. 2012, 45 (6) 402-7
29. Eissa, S.; Salem, A. M.; Zohny, S. F.; Hegazy, M. G. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology Cancer Biomark. 2007, 3 (6) 275-85
30. Oguztuzun, S.; Sezgin, Y.; Yazici, S.; Firat, P.; Ozhavzali, M.; Ozen, H. Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells Urol. Oncol. 2011, 29 (5) 538-44
31. Kim, W. J.; Kim, S. K.; Jeong, P.; Yun, S. J.; Cho, I. C.; Kim, I. Y.; Moon, S. K.; Um, H. D.; Choi, Y. H. A four-gene signature predicts disease progression in muscle invasive bladder cancer Mol. Med. 2011, 17 (5-6) 478-85
32. Jo, J. O.; Kang, Y. J.; Ock, M. S.; Kleinman, H. K.; Chang, H. K.; Cha, H. J. Thymosin beta4 expression in human tissues and in tumors using tissue microarrays Appl. Immunohistochem. Mol. Morphol. 2011, 19 (2) 160-7
33. Tran, M. N.; Choi, W.; Wszolek, M. F.; Navai, N.; Lee, I. L.; Nitti, G.; Wen, S.; Flores, E. R.; Siefker-Radtke, A.; Czerniak, B.; Dinney, C.; Barton, M.; McConkey, D. J. The p63 protein isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205 J. Biol. Chem. 2013, 288 (5) 3275-88
34. Shiota, M.; Yokomizo, A.; Itsumi, M.; Uchiumi, T.; Tada, Y.; Song, Y.; Kashiwagi, E.; Masubuchi, D.; Naito, S. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells BJU Int. 2011, 108 (2 Pt 2) E142-9
35. Higuchi, T.; Shimizu, M.; Owaki, A.; Takahashi, M.; Shinya, E.; Nishimura, T.; Takahashi, H. A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth Cancer Immunol. Immunother. 2009, 58 (8) 1245-55
36. Shakoori, A. R.; Hoessli, D. C. Nasir ud, D., Post-translational modifications in activation and inhibition of Oct-1-DNA binding complex in H2B and other diverse gene regulation: prediction of interplay sites J. Cell. Biochem. 2013, 114 (2) 266-74
37. Lee, H. S.; Park, J. H.; Kim, S. J.; Kwon, S. J.; Kwon, J. A cooperative activation loop among SWI/SNF, gamma-H2AX and H3 acetylation for DNA double-strand break repair EMBO J. 2010, 29 (8) 1434-45
38. Mahajan, M. A.; Murray, A.; Samuels, H. H. NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC Mol. Cell. Biol. 2002, 22 (19) 6883-94
39. Garapaty, S.; Mahajan, M. A.; Samuels, H. H. Components of the CCR4-NOT complex function as nuclear hormone receptor coactivators via association with the NRC-interacting Factor NIF-1 J. Biol. Chem. 2008, 283 (11) 6806-16
40. Passeron, T.; Valencia, J. C.; Namiki, T.; Vieira, W. D.; Passeron, H.; Miyamura, Y.; Hearing, V. J. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid J. Clin. Invest. 2009, 119 (4) 954-63
41. Protheroe, A. S.; Banks, R. E.; Mzimba, M.; Porter, W. H.; Southgate, J.; Singh, P. N.; Bosomworth, M.; Harnden, P.; Smith, P. H.; Whelan, P.; Selby, P. J. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer Br. J. Cancer 1999, 80 (1-2) 273-8
42. Hemmingsen, L.; Rasmussen, F.; Skaarup, P.; Wolf, H. Urinary protein profiles in patients with urothelial bladder tumours Br. J. Urol. 1981, 53 (4) 324-9
43. Mischak, H.; Allmaier, G.; Apweiler, R.; Attwood, T.; Baumann, M.; Benigni, A.; Bennett, S. E.; Bischoff, R.; Bongcam-Rudloff, E.; Capasso, G.; Coon, J. J.; D'Haese, P.; Dominiczak, A. F.; Dakna, M.; Dihazi, H.; Ehrich, J. H.; Fernandez-Llama, P.; Fliser, D.; Frokiaer, J.; Garin, J.; Girolami, M.; Hancock, W. S.; Haubitz, M.; Hochstrasser, D.; Holman, R. R.; Ioannidis, J. P.; Jankowski, J.; Julian, B. A.; Klein, J. B.; Kolch, W.; Luider, T.; Massy, Z.; Mattes, W. B.; Molina, F.; Monsarrat, B.; Novak, J.; Peter, K.; Rossing, P.; Sanchez-Carbayo, M.; Schanstra, J. P.; Semmes, O. J.; Spasovski, G.; Theodorescu, D.; Thongboonkerd, V.; Vanholder, R.; Veenstra, T. D.; Weissinger, E.; Yamamoto, T.; Vlahou, A. Recommendations for biomarker identification and qualification in clinical proteomics Sci. Transl. Med. 2010, 2 (46) 46ps42
44. Mischak, H.; Ioannidis, J. P.; Argiles, A.; Attwood, T. K.; Bongcam-Rudloff, E.; Broenstrup, M.; Charonis, A.; Chrousos, G. P.; Delles, C.; Dominiczak, A.; Dylag, T.; Ehrich, J.; Egido, J.; Findeisen, P.; Jankowski, J.; Johnson, R. W.; Julien, B. A.; Lankisch, T.; Leung, H. Y.; Maahs, D.; Magni, F.; Manns, M. P.; Manolis, E.; Mayer, G.; Navis, G.; Novak, J.; Ortiz, A.; Persson, F.; Peter, K.; Riese, H. H.; Rossing, P.; Sattar, N.; Spasovski, G.; Thongboonkerd, V.; Vanholder, R.; Schanstra, J. P.; Vlahou, A. Implementation of proteomic biomarkers: making it work Eur. J. Clin. Invest. 2012, 42 (9) 1027-36
45. Vicent, G. P.; Nacht, A. S.; Font-Mateu, J.; Castellano, G.; Gaveglia, L.; Ballare, C.; Beato, M. Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation Genes Dev. 2011, 25 (8) 845-62
46. Xiao, A.; Li, H.; Shechter, D.; Ahn, S. H.; Fabrizio, L. A.; Erdjument-Bromage, H.; Ishibe-Murakami, S.; Wang, B.; Tempst, P.; Hofmann, K.; Patel, D. J.; Elledge, S. J.; Allis, C. D. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity Nature 2009, 457 (7225) 57-62
47. Ogiwara, H.; Ui, A.; Otsuka, A.; Satoh, H.; Yokomi, I.; Nakajima, S.; Yasui, A.; Yokota, J.; Kohno, T. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors Oncogene 2011, 30 (18) 2135-46
48. Holland, D. G.; Burleigh, A.; Git, A.; Goldgraben, M. A.; Perez-Mancera, P. A.; Chin, S. F.; Hurtado, A.; Bruna, A.; Ali, H. R.; Greenwood, W.; Dunning, M. J.; Samarajiwa, S.; Menon, S.; Rueda, O. M.; Lynch, A. G.; McKinney, S.; Ellis, I. O.; Eaves, C. J.; Carroll, J. S.; Curtis, C.; Aparicio, S.; Caldas, C. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium EMBO Mol. Med. 2011, 3 (3) 167-80
49. Kim, T. H.; Chiera, S. L.; Linder, K. E.; Trempus, C. S.; Smart, R. C.; Horowitz, J. M. Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility to wound- and carcinogen-induced tumorigenesis Cancer Res. 2010, 70 (21) 8507-16
50. Segil, N.; Roberts, S. B.; Heintz, N. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity Science 1991, 254 (5039) 1814-6
51. Maddox, J.; Shakya, A.; South, S.; Shelton, D.; Andersen, J. N.; Chidester, S.; Kang, J.; Gligorich, K. M.; Jones, D. A.; Spangrude, G. J.; Welm, B. E.; Tantin, D. Transcription factor Oct1 is a somatic and cancer stem cell determinant PLoS Genet. 2012, 8 (11) e1003048
52. Yoshikawa, M.; Mukai, Y.; Okada, Y.; Tsumori, Y.; Tsunoda, S. I.; Tsutsumi, Y.; Aird, W. C.; Yoshioka, Y.; Okada, N.; Doi, T.; Nakagawa, S. Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody Blood 2013, 12, 468363
53. Chen, W. F.; Gao, W. D.; Li, Q. L.; Zhou, P. H.; Xu, M. D.; Yao, L. Q. SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3beta signaling pathway Int. J. Colorectal Dis. 2013, 28, 933
54. El Hour, M.; Moncada-Pazos, A.; Blacher, S.; Masset, A.; Cal, S.; Berndt, S.; Detilleux, J.; Host, L.; Obaya, A. J.; Maillard, C.; Foidart, J. M.; Ectors, F.; Noel, A.; Lopez-Otin, C. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis Oncogene 2010, 29 (20) 3025-32
55. Minder, P.; Bayha, E.; Becker-Pauly, C.; Sterchi, E. E. Meprinalpha transactivates the epidermal growth factor receptor (EGFR) via ligand shedding, thereby enhancing colorectal cancer cell proliferation and migration J. Biol. Chem. 2012, 287 (42) 35201-11